Stanford School of Medicine

In mice, a decline in how well one immune cell clears out another appears to drive aging throughout the body, a finding that could inform future treatments for age-related decline.

Stanford Medicine’s David Relman transformed clinical diagnostics and food tracing for cyclospora, the parasitic organism behind the surge of this diarrheal illness. Here’s what he thinks you should know.

A new Stanford Medicine study finds differences in how autistic teens process unfamiliar voices, pointing toward new therapies for adolescents.

In a new Stanford study, a slow, patient-controlled approach helped about half of chronic pain patients cut their opioid dose by half – without increased pain – over one year.

Colorectal cancer is now the No. 1 cause of cancer deaths among people under age 50. Here’s what Stanford Medicine experts want you to know.

Meet the Stanford Medicine emergency physicians and nurses who helped safeguard athletes and officials during FIFA World Cup games at Levi’s Stadium.

Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.

Antibody therapies show limited success in solid tumors. A new Stanford Medicine imaging method, precise enough to locate antibodies at subcellular resolution, hints at why.

Family- and individual-based therapy both improve eating variety in children with the pediatric eating disorder ARFID.

How do the drugs work? What happens if you stop? Is it safe to take them long term? Clinicians share everything you need to know about GLP-1 agonists.